UNSPSC 51341500: Antiviral carboxylic acids

Antiviral drugs made from organic compounds containing the carboxy group (-COOH).

UNSPSC 51341500 Antiviral carboxylic acids, a Class code, shows minimal alignment between its nominal scope and recent state and local procurement activity. The recent opportunities posted under this code span medical and pharmaceutical supplies well outside the narrow definition of antiviral carboxylic acids — including naloxone (an opioid antagonist), generic multi-source pharmaceuticals and OTC products, direct-to-manufacturer prescription programs, and emergency medical supplies such as respiratory equipment and cardiac monitoring devices. The issuing bodies include county health departments, state health and human services agencies, municipal fire departments, and cooperative purchasing organizations serving multiple jurisdictions. The mismatch between the code's chemical taxonomy and the actual procurement scope suggests either broad application of this code by state and local procurement offices to cover pharmaceutical and medical supply categories generally, or tagging inconsistency in the underlying opportunity database.

Geographic activity spans Florida, Texas, Minnesota, and Oregon, with representation from a single county health authority (Seminole County), state-level agencies (Texas HHS Commission, Minnesota Department of Administration), and municipal purchasing (City of Tampa). Representative recent solicitations include Seminole County's IFB60459723LAS for 1,900 units of naloxone and 800 safe drug deactivation systems annually with a July 26, 2023 response deadline; the City of Tampa's IFB 26P00145 for 169 line items of medical and first aid supplies for the Fire Department Rescue Division, estimated at $700,000.00, with a March 13, 2026 deadline and a 5 percent bid discount sheltered for certified Small Local Business Enterprises; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products across participating state and local facilities in multiple states, with proposals due March 26, 2026 and contract effectiveness July 1, 2026. The UNSPSC code shows little recent activity genuinely anchored to antiviral carboxylic acid chemistry.